This study discusses how ROS interacts with microglia in the striatum of patients with advanced neurodegenerative diseases based on the region-specific alteration in levels of microglial neurobiological phenotypes: MPO, PAR, and TREM2. The gene discussed is MPO; the disease is neurodegenerative disease.